Clinlab Navigator

Isocitrate Dehydrogenase Mutations

Isocitrate dehydrogenase (IDH) normally catalyzes the oxidative decarboxylation of isocitrate to α-ketoglutarate. IDH1 is a cytosolic enzyme that results in production of NADPH. It should not be confused with IDH2 which is an isoenzyme in the citric acid cycle that reduces NAD rather than NADP.  Mutations in IDH1 and IDH2 occur in a number of cancer types including ~20% of acute myeloid leukemias (AML).  IDH mutants gain the novel capacity to reduce α-ketoglutarate to D-2-hydroxyglutarate. D-2-hydroxyglutarate is known as an oncometabolite and its accumulation competitively inhibits α-ketoglutarate dependent enzyme activities including methlycytosine hydroxylation by members of the TET gene family and histone lysine demethylases belonging to the JMJD family. Such metabolic derangement promotes genetic hypermethylation and in the case of AML, leads to arrested differentiation of myeloid progenitors. 

IDH mutations have been identified in over 70% of lower-grade (II/III) diffuse gliomas and secondary glioblastoma. Assessment of IDH mutation status in central nervous system tumors assists in tumor classification and provide prognostic information for patients with diffuse gliomas.

Point mutations and small insertion/deletion mutations in the IDH1 and IDH2 genes are detected by next generation sequencing. Enasidenib and Ivosidenib are inhibitors of isocitrate dehydrogenase–1.

Updated Articles

Fecal Occult Blood…

Colorectal cancer is the only major cancer that affects men and women almost equally. It is rare in persons under age 40, but the incidence begins to rise substantially after age 50. About 6% of people develop colorectal cancer by 80 years of age…

New Articles

Transthyretin…

Transthyretin (TTR) is a plasma protein that is synthesized by the liver and transports thyroxine (thyroid hormone) and retinol (vitamin A). TTR is also known as prealbumin and normally circulates in the plasma as a homotetramer. When these…

Blog

At-Home Testing for…

Sexually transmitted infections (STIs), particularly chlamydia and gonorrhea, continue to be major public health concerns in the US. In 2022, reported rates were 495.0 and 194.4 per 100 000 people, respectively. If left untreated, these diseases can…